Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs 
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Hyundai Takes Full Control of Boston Dynamics to Accelerate Humanoid Robot and AI Strategy 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
WINTER SPRINGS, Fla., Jan. 22, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2015 fourth quarter financial results before the market opens on Friday, February 5th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering reservation code 37106645.
The conference call will also be available real-time via the Internet at www.iradimed.com/en-us/investors/index.php and selecting Events & Presentations. A recording of the call will be available on the Company’s website for 90 days following completion of the call.
About IRADIMED CORPORATION
IRADIMED CORPORATION is the only known provider of non-magnetic intravenous (“IV”) infusion pump systems that are specifically designed to be safe for use during magnetic resonance imaging (“MRI”) procedures. We were the first to develop an infusion delivery system that neutralizes the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency (“RF”) interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our MRidium MRI compatible IV infusion pump system has been designed with a patented non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated in order to remain immobile during an MRI scan.
Media Contact: Chris Scott Chief Financial Officer IRADIMED CORPORATION (407) 677-8022 [email protected]
